Some review and maybe something new.
Recent research on fluid biomarkers in multiple sclerosis (MS) frames an emerging picture of two aspects of the disease: inflammatory activity measured with neurofilament light chain (NfL), and disease progression independent of relapses, with promising results suggested by emerging markers like glial fibrillary acidic protein (GFAP).
Great article. Anything that helps the understanding PIRA sounds hopeful.
HEALTH NEWSNew Drug Shows Promise in Treating Secondary Progressive Multiple SclerosisPET Brain Scans Find ‘Smoldering’ Inflammation in Multiple Sclerosis Patients
You have relapsing Remitting Multiple Sclerosis.DMTs in Aging MS Patients: When and How to StopCan You Donate Blood If You Have Diabetes or Multiple Sclerosis?
